• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Skowron Anna

    12/29/25 5:31:37 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GRDX alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Skowron Anna

    (Last) (First) (Middle)
    C/O GRIDAI TECHNOLOGIES CORP.
    777 YAMATO ROAD, SUITE 502

    (Street)
    BOCA RATON FL 33431

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/07/2025
    3. Issuer Name and Ticker or Trading Symbol
    GridAI Technologies Corp. [ GRDX ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Interim CFO
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Anna Skowron 12/29/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GRDX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GRDX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Powell Max Limited Successfully Repositions for Its Next Phase of Growth

    Hong Kong, TX, March 09, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (NASDAQ:PMAX) ("Powell Max" or the "Company"), a financial communications services provider, is pleased to provide the following corporate update regarding its successful repositioning. Key Highlights: Raised $17 million in capital from new investorsAppointed new Chairman and Chief Executive Officer Geordan PursgloveReconstituted the Board of DirectorsRegained compliance with Nasdaq listing requirements Powell Max Chairman and Chief Executive Officer Geordan Pursglove commented, "My first month at Powell Max has been extremely productive. We successfully completed a corporate restructuring in a short timeframe, raised

    3/9/26 8:30:00 AM ET
    $ALBT
    $CISO
    $GRDX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Professional Services
    Consumer Discretionary

    IBN Announces Latest Episode of The TechMediaWire Podcast featuring Marshall Chapin, CEO of Grid AI Corp.

    AUSTIN, Texas, March 05, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The TechMediaWire Podcast delivers informative updates and exclusive interviews with executives operating in the tech industry. The TechMediaWire Podcast's latest episode features Marshall Chapin, CEO of Grid AI Corp., wholly-owned by GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent en

    3/5/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

    BOCA RATON, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent energy orchestration for hyperscale AI data centers, today announced the appointment of Tim Healy as Executive Chairman of the Board of Grid AI Corp., the Company's wholly owned operating subsidiary. Healy brings more than two decades of experience as a founder, CEO, board leader, and investor across the energy technology and energy transition landscape. Over his career, he has founded multiple public companies, establishing a track record of scaling innovative platforms from early commercialization through global deployment and strategic exits

    2/4/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRDX
    SEC Filings

    View All

    $GRDX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GridAI Technologies Corp.

    SCHEDULE 13G/A - GridAI Technologies Corp. (0001604191) (Subject)

    2/12/26 2:14:12 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

    8-K - GridAI Technologies Corp. (0001604191) (Filer)

    1/7/26 4:05:41 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GridAI Technologies Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - GridAI Technologies Corp. (0001604191) (Filer)

    12/23/25 4:10:54 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Borkowski Edward was granted 40,000 shares, increasing direct ownership by 198% to 60,248 units (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/8/26 5:28:29 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Uppal Manpreet was granted 40,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/5/26 5:24:51 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Pursglove Geordan Garrett was granted 40,000 shares (SEC Form 4)

    4 - GridAI Technologies Corp. (0001604191) (Issuer)

    1/5/26 4:57:27 PM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRDX
    Leadership Updates

    Live Leadership Updates

    View All

    GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

    BOCA RATON, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (NASDAQ:GRDX), a technology company focused on intelligent energy orchestration for hyperscale AI data centers, today announced the appointment of Tim Healy as Executive Chairman of the Board of Grid AI Corp., the Company's wholly owned operating subsidiary. Healy brings more than two decades of experience as a founder, CEO, board leader, and investor across the energy technology and energy transition landscape. Over his career, he has founded multiple public companies, establishing a track record of scaling innovative platforms from early commercialization through global deployment and strategic exits

    2/4/26 8:00:00 AM ET
    $GRDX
    Biotechnology: Pharmaceutical Preparations
    Health Care